Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cytokine-inhibitory pyrimidines under evaluation at AstraZeneca

May 28, 2001

Imidazole-based cytokine inhibitors designed at Merck & Co.

May 21, 2001

U.S. Army to test CT-3 in vivo

May 21, 2001

Small molecules from Genentech inhibit interaction between alpha4 integrins and their ligands

May 16, 2001

Humanized antibody safe and effective in phase I/II studies in RA patients

May 16, 2001

Long-term safety and efficacy of adalimumab demonstrated in active RA

May 16, 2001

Active metabolite of leflunomide proven to suppress eotaxin production

May 15, 2001

KS Biomedix moves KSB-302 into phase IIb for RA

May 14, 2001

Dimethaid Research seeks approval of Pennsaid via mutual recognition procedure

May 11, 2001

Binding, functional and immunological activity described for HS-378 in Noordwijkerhout

May 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...